Literature DB >> 24932429

Refined Data Analysis Provides Clinical Evidence for Central Nervous System Control of Chronic Glaucomatous Neurodegeneration.

William E Sponsel1, Sylvia L Groth2, Nancy Satsangi3, Ted Maddess4, Matthew A Reilly5.   

Abstract

PURPOSE: Refined data analysis was performed to assess binocular visual field conservation in patients with bilateral glaucomatous damage to determine whether unilateral visual field loss is random, anatomically symmetric, or nonrandom in relation to the fellow eye.
METHODS: This was a case-control study of 47 consecutive patients with bilaterally severe glaucoma; each right eye visual field locus was paired with randomly selected coisopteric left eye loci, with 760,000 (10,000 complete sets of 76 loci) such iterations performed per subject. The potential role of anatomic symmetry in bilateral visual field conservation was also assessed by pairing mirror-image loci of the paired fields. The mean values of the random coisopteric and the symmetric mirror pairings were compared with natural point-for-point pairings of the two eyes by paired t-test.
RESULTS: Mean unilateral thresholds across the entire visual field were 18.9 dB left and 19.9 dB right (average 19.4), 4 dB lower than the better of the naturally paired concomitant loci of 23.4 dB (P < 10-15). A remarkable natural tendency for conservation of the binocular visual field was confirmed, far stronger than explicable by random chance or anatomic symmetry (P < 0.0001), and reaffirmed by subsequent prospective simultaneous binocular visual field retesting of an arbitrary subset (n = 16) of the study population (P < 0.0001).
CONCLUSIONS: Refined data analysis of paired visual fields confirms the existence of a natural optimization of binocular visual function in severe bilateral glaucoma via interlocking fields that could be created only by central nervous system (CNS) involvement. TRANSLATIONAL RELEVANCE: Integrated bilateral visual field analysis should better define actual visual disability and more accurately reflect the functional efficacy of current ocular and future CNS-oriented therapeutic approaches to the treatment of glaucoma. Glaucomatous eyes provide a highly accessible paired-organ study model for developing therapeutics to optimize conservation of function in neurodegenerative disorders.

Entities:  

Keywords:  Refined data analysis; glaucoma; neurodegeneration; neuroprotection; perimetry; visual fields

Year:  2014        PMID: 24932429      PMCID: PMC4043108          DOI: 10.1167/tvst.3.3.1

Source DB:  PubMed          Journal:  Transl Vis Sci Technol        ISSN: 2164-2591            Impact factor:   3.283


  42 in total

1.  Retinal ganglion cell death in experimental glaucoma.

Authors:  J E Morgan; H Uchida; J Caprioli
Journal:  Br J Ophthalmol       Date:  2000-03       Impact factor: 4.638

Review 2.  Critical pathogenic events underlying progression of neurodegeneration in glaucoma.

Authors:  David J Calkins
Journal:  Prog Retin Eye Res       Date:  2012-08-01       Impact factor: 21.198

3.  Distal axonopathy with structural persistence in glaucomatous neurodegeneration.

Authors:  Samuel D Crish; Rebecca M Sappington; Denise M Inman; Philip J Horner; David J Calkins
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-01       Impact factor: 11.205

4.  Differential induction of c-Fos and c-Jun in the lateral geniculate nucleus of rats following unilateral optic nerve injury with contralateral retinal blockade.

Authors:  Yi Dai; Xinghuai Sun; Qian Chen
Journal:  Exp Brain Res       Date:  2008-10-15       Impact factor: 1.972

Review 5.  Glaucoma of the brain: a disease model for the study of transsynaptic neural degeneration.

Authors:  Yeni Yücel; Neeru Gupta
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

6.  Morphology of single ganglion cells in the glaucomatous primate retina.

Authors:  A J Weber; P L Kaufman; W C Hubbard
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-11       Impact factor: 4.799

7.  The visuotopic organization of the superior colliculus of the owl monkey (Aotus trivirgatus) and the bush baby (Galago senegalensis).

Authors:  R H Lane; J M Allman; J H Kaas; F M Miezin
Journal:  Brain Res       Date:  1973-10-12       Impact factor: 3.252

8.  Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex.

Authors:  N Gupta; L-C Ang; L Noël de Tilly; L Bidaisee; Y H Yücel
Journal:  Br J Ophthalmol       Date:  2006-02-07       Impact factor: 4.638

9.  Changes in visual fields and lateral geniculate nucleus in monkey laser-induced high intraocular pressure model.

Authors:  Masaaki Sasaoka; Katsuki Nakamura; Masamitsu Shimazawa; Yasushi Ito; Makoto Araie; Hideaki Hara
Journal:  Exp Eye Res       Date:  2008-02-26       Impact factor: 3.467

10.  Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric.

Authors:  Cassandra L Schlamp; Yan Li; Joel A Dietz; Katherine T Janssen; Robert W Nickells
Journal:  BMC Neurosci       Date:  2006-10-03       Impact factor: 3.288

View more
  13 in total

1.  Extraordinary Claims Require Extraordinary Evidence: Centrally Mediated Preservation of Binocular Visual Field in Glaucoma is Unlikely.

Authors:  Jonathan Denniss; Paul H Artes
Journal:  Transl Vis Sci Technol       Date:  2015-01-22       Impact factor: 3.283

2.  Definitive Response to Denniss and Artes: The Paired Eyes and Brain in One Person Are One Unit.

Authors:  William E Sponsel; Matthew A Reilly; Ted Maddess
Journal:  Transl Vis Sci Technol       Date:  2015-03-17       Impact factor: 3.283

3.  Axon hyperexcitability in the contralateral projection following unilateral optic nerve crush in mice.

Authors:  Nolan R McGrady; Joseph M Holden; Marcio Ribeiro; Andrew M Boal; Michael L Risner; David J Calkins
Journal:  Brain Commun       Date:  2022-10-03

4.  Refined Frequency Doubling Perimetry Analysis Reaffirms Central Nervous System Control of Chronic Glaucomatous Neurodegeneration.

Authors:  Matthew A Reilly; Analaura Villarreal; Ted Maddess; William Eric Sponsel
Journal:  Transl Vis Sci Technol       Date:  2015-06-08       Impact factor: 3.283

5.  Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control.

Authors:  Yolandi van der Merwe; Matthew C Murphy; Jeffrey R Sims; Muneeb A Faiq; Xiao-Ling Yang; Leon C Ho; Ian P Conner; Yu Yu; Christopher K Leung; Gadi Wollstein; Joel S Schuman; Kevin C Chan
Journal:  Neurotherapeutics       Date:  2021-04-13       Impact factor: 7.620

6.  Ocular Dominance in Open-angle Glaucoma: The Shifting Trend Depending on Stage of the Disease.

Authors:  Moon Young Choi; Jin A Choi
Journal:  Korean J Ophthalmol       Date:  2022-02-18

7.  Nonpenetrating Deep Sclerectomy for Progressive Glaucoma: Long-term (5-year) Follow-up of Intraocular Pressure Control and Visual Field Survival.

Authors:  Grant Slagle; Sylvia L Groth; Mario Montelongo; William E Sponsel
Journal:  J Curr Glaucoma Pract       Date:  2020 Jan-Apr

8.  Retinal Structures and Visual Cortex Activity are Impaired Prior to Clinical Vision Loss in Glaucoma.

Authors:  Matthew C Murphy; Ian P Conner; Cindy Y Teng; Jesse D Lawrence; Zaid Safiullah; Bo Wang; Richard A Bilonick; Seong-Gi Kim; Gadi Wollstein; Joel S Schuman; Kevin C Chan
Journal:  Sci Rep       Date:  2016-08-11       Impact factor: 4.379

9.  Association of Diopsys® Short-duration Transient Visual Evoked Potential Latency with Visual Field Progression in Chronic Glaucoma.

Authors:  Richard Trevino; William E Sponsel; Carolyn E Majcher; Joey Allen; Jeffery Rabin
Journal:  J Curr Glaucoma Pract       Date:  2018-03-01

10.  Pattern Electroretinography and Visual Evoked Potentials Provide Clinical Evidence of CNS Modulation of High- and Low-Contrast VEP Latency in Glaucoma.

Authors:  William E Sponsel; Susan L Johnson; Rick Trevino; Alberto Gonzalez; Sylvia L Groth; Carolyn Majcher; Diane C Fulton; Matthew A Reilly
Journal:  Transl Vis Sci Technol       Date:  2017-11-08       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.